<DOC>
	<DOCNO>NCT01717482</DOCNO>
	<brief_summary>The purpose study learn whether good receive drug Metformin standard care lung cancer standard care .</brief_summary>
	<brief_title>Metformin Chemoprevention Agent Non-small Cell Lung Cancer</brief_title>
	<detailed_description>Participants need schedule undergo surgical resection lung cancer Mayo Clinic Rochester , MN . They ask provide blood sample prior surgery . Samples tumor tissue normal lung tissue take sample remove lung surgery . The tissue use evaluate DNA . A skin biopsy edge incision already make do surgery . We take skin grow skin fibroblast . Then reprogram skin fibroblast induce pluripotent cell . You `` randomize '' one study group either take Metformin 6 month standard care follow receive standard care follow .</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Inclusion Criteria Suspected biopsy proven Stage IAIIIA lung squamous cell carcinoma ( must prove SCC time surgery ) Medically fit surgical resection ( base surgeon assessment ) Current prior smoker Age &gt; 18 year old Both Male Female Willing able consent study , undergo study intervention , take study drug ECOG performance status 0 , 1 , 2 Subject must start Metformin within 90 day surgery . Exclusion Criteria Currently take metformin diabetic drug Current previous congestive heart failure , renal failure liver failure Creatinine Women 1.4 great Creatinine Men 1.5 great Existing untreated prior cancer &lt; 5 year diagnosis Received neoadjuvant platinumbased chemotherapy target therapy Receiving adjuvant platinumbased chemotherapy target therapy surgical resection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bronchoscopy</keyword>
	<keyword>Metformin</keyword>
</DOC>